1. Home
  2. TWO vs IOVA Comparison

TWO vs IOVA Comparison

Compare TWO & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWO
  • IOVA
  • Stock Information
  • Founded
  • TWO 2009
  • IOVA 2007
  • Country
  • TWO United States
  • IOVA United States
  • Employees
  • TWO N/A
  • IOVA N/A
  • Industry
  • TWO Real Estate Investment Trusts
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TWO Real Estate
  • IOVA Health Care
  • Exchange
  • TWO Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • TWO 1.1B
  • IOVA 975.1M
  • IPO Year
  • TWO 2009
  • IOVA N/A
  • Fundamental
  • Price
  • TWO $9.66
  • IOVA $2.17
  • Analyst Decision
  • TWO Buy
  • IOVA Buy
  • Analyst Count
  • TWO 8
  • IOVA 11
  • Target Price
  • TWO $12.50
  • IOVA $11.90
  • AVG Volume (30 Days)
  • TWO 1.9M
  • IOVA 9.8M
  • Earning Date
  • TWO 10-27-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • TWO 16.18%
  • IOVA N/A
  • EPS Growth
  • TWO N/A
  • IOVA N/A
  • EPS
  • TWO N/A
  • IOVA N/A
  • Revenue
  • TWO $257,735,000.00
  • IOVA $241,525,000.00
  • Revenue This Year
  • TWO N/A
  • IOVA $68.14
  • Revenue Next Year
  • TWO N/A
  • IOVA $56.64
  • P/E Ratio
  • TWO N/A
  • IOVA N/A
  • Revenue Growth
  • TWO N/A
  • IOVA 636.99
  • 52 Week Low
  • TWO $9.50
  • IOVA $1.64
  • 52 Week High
  • TWO $14.28
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • TWO 42.15
  • IOVA 47.00
  • Support Level
  • TWO $9.60
  • IOVA $1.97
  • Resistance Level
  • TWO $10.22
  • IOVA $2.38
  • Average True Range (ATR)
  • TWO 0.17
  • IOVA 0.13
  • MACD
  • TWO -0.02
  • IOVA 0.02
  • Stochastic Oscillator
  • TWO 9.68
  • IOVA 51.22

About TWO Two Harbors Investment Corp

Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: